Repeated Tobacco-Use Screening and Intervention in Clinical Practice. Health Impact and Cost Effectiveness

American Journal of Preventive Medicine

Volumn 31, Issue 1, 2006, Pages

  Solberg, Leif I ^a   Maciosek, Michael V ^a   Edwards, Nichol M ^a   Khanchandani, Hema S ^a   Goodman, Michael J ^a  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; COUNSELING; DEATH; HUMAN; MORBIDITY; PREVENTIVE HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; SCREENING; SMOKING; SMOKING CESSATION;

EID: 33745473803     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2006.03.013     Document Type: Article

References (109)

1. Mokdad A.H., Marks J.S., Stroup D.F., and Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 291 (2004) 1238-1245
2. Fiore M.C., Bailey W.C., Cohen S.J., et al. Treating tobacco use and dependence (2000), U.S. Department of Health and Human Services, Public Health Service, Rockville MD June
3. Task Force on Community Preventive Services. Recommendations regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 20 suppl 2 (2001) 10-15
4. U.S. Preventive Services Task Force. Counseling to prevent tobacco use and tobacco-caused disease (2003). http://www.ahrq.gov/clinic/3rduspstf/tobacccoun/tobcounrs.pdf November. Available at: www.ahrq.gov/clinic/3rduspstf/tobacccoun/tobcounrs.pdf. Accessed July 1, 2005.
5. Quinn V.P., Stevens V.J., Hollis J.F., et al. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med 29 (2005) 77-84
6. National Committee for Quality Assurance. The state of health care quality (2005). http://www.ncqa.org/Docs/SOHCQ_2005.pdf Available at: www.ncqa.org/Docs/SOHCQ_2005.pdf. Accessed November 17, 2005.
7. Cokkinides V.E., Ward E., Jemal A., and Thun M.J. Under-use of smoking-cessation treatments. results from the National Health Interview Survey, 2000. Am J Prev Med 28 (2005) 119-122
8. Ockene J.K., Lindsay E.A., Hymowitz N., et al., COMMIT Research Group. Tobacco control activities of primary-care physicians in the Community Intervention Trial for Smoking Cessation. Tob Control 6 suppl 2 (1997) S49-S56
9. Halpern M.T., Khan Z.M., Young T.L., and Battista C. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. Am J Health Syst Pharm 57 (2000) 1421-1429
10. Croghan I.T., Offord K.P., Evans R.W., et al. Cost-effectiveness of treating nicotine dependence. the Mayo Clinic experience. Mayo Clin Proc 72 (1997) 917-924
11. Cromwell J., Bartosch W.J., Fiore M.C., Hasselblad V., and Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 278 (1997) 1759-1766
12. Cummings S.R., Rubin S.M., and Oster G. The cost-effectiveness of counseling smokers to quit. JAMA 261 (1989) 75-79
13. Curry S.J., Grothaus L.C., McAfee T., and Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 339 (1998) 673-679
14. Fiscella K., and Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 275 (1996) 1247-1251
15. Javitz H.S., Swan G.E., Zbikowski S.M., et al. Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation. a societal perspective. Am J Manag Care 10 (2004) 217-226
16. Levy D.T., and Friend K. A simulation model of policies directed at treating tobacco use and dependence. Med Decis Making 22 (2002) 6-17
17. McAlister A.L., Rabius V., Geiger A., Glynn T.J., Huang P., and Todd R. Telephone assistance for smoking cessation. one-year cost effectiveness estimations. Tob Control 13 (2004) 85-86
18. Meenan R.T., Stevens V.J., Hornbrook M.C., et al. Cost-effectiveness of a hospital-based smoking cessation intervention. Med Care 36 (1998) 670-678
19. Nielsen K., and Fiore M.C. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med 30 (2000) 209-216
20. Oster G., Huse D.M., Delea T.E., and Colditz G.A. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA 256 (1986) 1315-1318
21. Schauffler H.H., McMenamin S., Olson K., Boyce-Smith G., Rideout J.A., and Kamil J. Variations in treatment benefits influence smoking cessation. results of a randomized controlled trial. Tob Control 10 (2001) 175-180
22. Tran M.T., Holdford D.A., Kennedy D.T., and Small R.E. Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy 22 (2002) 1623-1631
23. Warner K.E., Smith R.J., Smith D.G., and Fries B.E. Health and economic implications of a work-site smoking-cessation program. a simulation analysis. J Occup Environ Med 38 (1996) 981-992
24. Warner K.E., Mendez D., and Smith D.G. The financial implications of coverage of smoking cessation treatment by managed care organizations. Inquiry 41 (2004) 57-69
25. Wasley M.A., McNagny S.E., Phillips V.L., and Ahluwalia J.S. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med 26 (1997) 264-270
26. Buck D.J., Richmond R.L., and Mendelsohn C.P. Cost-effectiveness analysis of a family physician delivered smoking cessation program. Prev Med 31 (2000) 641-648
27. Crealey G.E., McElnay J.C., Maguire T.A., and O'Neill C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 14 (1998) 323-333
28. Haycox A. A methodology for estimating the costs and benefits of health promotion. Health Promot Int 9 (1994) 5-11
29. Lennox A.S., Osman L.M., Reiter E., et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice. randomised controlled trial. BMJ 322 (2001) 1396
30. Mudde A.N., de Vries H., and Strecher V.J. Cost-effectiveness of smoking cessation modalities. comparing apples with oranges?. Prev Med 25 (1996) 708-716
31. Orme M.E., Hogue S.L., Kennedy L.M., Paine A.C., and Godfrey C. Development of the health and economic consequences of smoking interactive model. Tob Control 10 (2001) 55-61
32. Parrott S., Godfrey C., Raw M., West R., and McNeill A. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax 53 suppl 5 (1998) S1-S38
33. Plans-Rubio P. Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease evaluative study carried out in Spain. Pharmacoeconomics 13 (1998) 623-643
34. Ranson M.K., Jha P., Chaloupka F.J., and Nguyen S.N. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine Tob Res 4 (2002) 311-319
35. Song F., Raftery J., Aveyard P., Hyde C., Barton P., and Woolacott N. Cost-effectiveness of pharmacological interventions for smoking cessation. a literature review and a decision analytic analysis. Med Decis Making 22 suppl 5 (2002) S26-S37
36. Stapleton J.A., Lowin A., and Russell M.A. Prescription of transdermal nicotine patches for smoking cessation in general practice. evaluation of cost-effectiveness. Lancet 354 (1999) 210-215
37. Woolacott N.F., Jones L., Forbes C.A., et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation. a systematic review and economic evaluation. Health Technol Assess 6 (2002) 1-245
38. Coffield A.B., Maciosek M.V., McGinnis J.M., et al. Priorities among recommended clinical preventive services. Am J Prev Med 21 (2001) 1-9
39. Maciosek M.V., Coffield A.B., Edwards N.M., Flottemesch T.J., Goodman M.J., and Solberg L.I. Priorities among effective clinical preventive services. results of a systematic review and analysis. Am J Prev Med 31 (2006) 52-61
40. Maciosek M.V., Edwards N.M., Coffield A.B., et al. Priorities among effective clinical preventive services. methods. Am J Prev Med 31 (2006) 90-96
41. Maciosek M.V., Edwards N.M., Solberg L.I., et al. Technical report of the National Commission on Prevention Priorities. methods update for priority setting among effective clinical preventive services (2005). http://prevent.org/ncpp Available at: prevent.org/ncpp. Accessed May 2006.
42. Yudkin P., Hey K., Roberts S., Welch S., Murphy M., and Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 327 (2003) 28-29
43. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care. results of the OXCHECK study after one year. BMJ 308 (1994) 308-312
44. Lancaster T., Stead L., Silagy C., and Sowden A. Effectiveness of interventions to help people stop smoking. findings from the Cochrane Library. BMJ 5 (2000) 355-358
45. Hollis J.F., Lichtenstein E., Vogt T.M., Stevens V.J., and Biglan A. Nurse-assisted counseling for smokers in primary care. Ann Intern Med 118 (1993) 521-525
46. Segnan N., Ponti A., Battista R.N., et al. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control 2 (1991) 239-246
47. Killen J.D., Fortmann S.P., Newman B., and Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58 (1990) 85-92
48. Killen J.D., Fortmann S.P., Davis L., and Varady A. Nicotine patch and self-help video for cigarette smoking cessation. J Consult Clin Psychol 65 (1997) 663-672
49. Hughes G.H., Hymowitz N., Ockene J.K., Simon N., and Vogt T.M. The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking. Prev Med 10 (1981) 476-500
50. Pieterse M.E., Seydel E.R., DeVries H., Mudde A.N., and Kok G.J. Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners. a randomized controlled trial. Prev Med 32 (2001) 182-190
51. Curry S.J., Ludman E.J., Graham E., Stout J., Grothaus L., and Lozano P. Pediatric-based smoking cessation intervention for low-income women. a randomized trial. Arch Pediatr Adolesc Med 157 (2003) 295-302
52. Burton L.C., Paglia M.J., German P.S., Shapiro S., and Damiano A.M. The effect among older persons of a general preventive visit on three health behaviors. smoking, excessive alcohol drinking, and sedentary lifestyle. The Medicare Preventive Services Research Team. Prev Med 24 (1995) 492-497
53. Russell M.A., Stapleton J.A., Jackson P.H., Hajek P., and Belcher M. District programme to reduce smoking. effect of clinic supported brief intervention by general practitioners. BMJ (Clin Res Ed) 295 (1987) 1240-1244
54. Imperial Cancer Research Fund, General Practice Research Group. Randomised trial of nicotine patches in general practice. results at one year. BMJ 308 (1994) 1476-1477
55. Daughton D., Susman J., Sitorius M., et al., The Nebraska Primary Practice Smoking Cessation Trial Group. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. Arch Fam Med 7 (1998) 425-430
56. Slama K., Redman S., Perkins J., Reid A.L., and Sanson-Fisher R.W. The effectiveness of two smoking cessation programmes for use in general practice. a randomised clinical trial. BMJ 300 (1990) 1707-1709
57. Jamrozik K., Vessey M., Fowler G., Wald N., Parker G., and Van Vunakis H. Controlled trial of three different antismoking interventions in general practice. BMJ (Clin Res Ed) 288 (1984) 1499-1503
58. Russell M.A., Merriman R., Stapleton J., and Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. BMJ (Clin Res Ed) 287 (1983) 1782-1785
59. Russell M.A., Wilson C., Taylor C., and Baker C.D. Effect of general practitioners' advice against smoking. BMJ 2 (1979) 231-235
60. Demers R.Y., Neale A.V., Adams R., Trembath C., and Herman S.C. The impact of physicians' brief smoking cessation counseling. a MIRNET study. J Fam Pract 31 (1990) 625-629
61. Stewart P.J., and Rosser W.W. The impact of routine advice on smoking cessation from family physicians. CAMJ 126 (1982) 1051-1054
62. Tonnesen P., Mikkelsen K., Markholst C., et al. Nurse-conducted smoking cessation with minimal intervention in a lung clinic. a randomized controlled study. Eur Respir J 9 (1996) 2351-2355
63. Aveyard P., Griffin C., Lawrence T., and Cheng K.K. A controlled trial of an expert system and self-help manual intervention based on the stages of change versus standard self-help materials in smoking cessation. Addiction 98 (2003) 345-354
64. Grandes G., Cortada J.M., and Arrazola A. An evidence-based programme for smoking cessation. effectiveness in routine general practice. Br J Gen Pract 50 (2000) 803-807
65. Maciosek M.V., Coffield A.B., McGinnis J.M., et al. Methods for priority setting among clinical preventive services. Am J Prev Med 21 (2001) 10-19
66. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Available at: www.cdc.gov/brfss/. Accessed June 13, 2005.
67. Rogers R.G., and Powell-Griner E. Life expectancies of cigarette smokers and nonsmokers in the United States. Soc Sci Med 32 (1991) 1151-1159
68. Taylor Jr. D.H., Hasselblad V., Henley S.J., Thun M.J., and Sloan F.A. Benefits of smoking cessation for longevity. Am J Public Health 92 (2002) 990-996
69. Musich S., Faruzzi S.D., Lu C., McDonald T., Hirschland D., and Edington D.W. Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain. Am J Health Promot 18 (2003) 133-142
70. Rosenbaum W.L., Sterling T.D., and Weinkam J.J. Use of multiple surveys to estimate mortality among never, current, and former smokers. changes over a 20-year interval. Am J Public Health 88 (1998) 1664-1668
71. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking. 50 years' observations on male British doctors. BMJ 328 (2004) 1519
72. Kiiskinen U., Vartiainen E., Puska P., and Pekurinen M. Smoking-related costs among 25 to 59 year-old males in a 19-year individual follow-up. Eur J Public Health 12 (2002) 145-151
73. Pronk N.P., Goodman M.J., O'Connor P.J., and Martinson B.C. Relationship between modifiable health risks and short-term health care charges. JAMA 282 (1999) 2235-2239
74. Terry P.E., Fowler E.J., and Fowles J.B. Are health risks related to medical care charges in the short-term? Challenging traditional assumptions. Am J Health Promot 12 (1998) 340-347
75. Zhu S., Melcer T., Sun J., Rosbrook B., and Pierce J.P. Smoking cessation with and without assistance. a population-based analysis. Am J Prev Med 18 (2000) 305-311
76. Levinson A.H., Perez-Stable E.J., Espinoza P., Flores E.T., and Byers T.E. Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 26 (2004) 105-111
77. Office on Smoking and Health. The health benefits of smoking cessation (1990), U.S. Department of Health and Human Services, Office on Smoking and Health, Rockville MD
78. Ingenix. National fee analyzer charge data for evaluating fees nationally (2004), Ingenix, Salt Lake City UT
79. Bureau of Labor Statistics. Employer costs for employee compensation historical listing (annual), 1986-2001 (2002), Bureau of Labor Statistics, Washington DC June 19
80. Miller V.P., Ernst C., and Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med 48 (1999) 375-391
81. Wagner E.H., Curry S.J., Grothaus L., Saunders K.W., and McBride C.M. The impact of smoking and quitting on health care use. Arch Intern Med 155 (1995) 1789-1795
82. Fishman P.A., Khan Z.M., Thompson E.E., and Curry S.J. Health care costs among smokers, former smokers, and never smokers in an HMO. Health Serv Res 38 (2003) 733-749
83. Martinson B.C., O'Connor P.J., Pronk N.P., and Rolnick S.J. Smoking cessation attempts in relation to prior health care charges. the effect of antecedent smoking-related symptoms?. Am J Health Promot 18 (2003) 125-132
84. Warner K.E. The costs of benefits. smoking cessation and health care expenditures. Am J Health Promot 18 (2003) 123-124 ii
85. Keehan S.P., Lazenby H.C., Zezza M.A., and Catlin A.C. Age estimates in the national health accounts. Health Care Financ Rev 1 (2004) 1-16
86. Hoffman Jr. E.D., Klees B.S., and Curtis C.A. Overview of the Medicare and Medicaid programs. Health Care Financ Rev suppl (2001) 1-376 (statistical supplement).
87. Miller L.S., Zhang X., Rice D.P., and Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep 113 (1998) 447-458
88. Warner K.E., Hodgson T.A., and Carroll C.E. Medical costs of smoking in the United States. estimates, their validity, and their implications. Tob Control 8 (1999) 290-300
89. Rice D.P., Hodgson T.A., Sinsheimer P., Browner W., and Kopstein A.N. The economic costs of the health effects of smoking, 1984. Milbank Q 64 (1986) 489-547
90. Lancaster T., and Stead L.F. Physician advice for smoking cessation. Cochrane Database Syst Rev (2004) CD000165.pub2
91. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) CD000146
92. Solberg L.I., Maxwell P.L., Kottke T.E., Gepner G.J., and Brekke M.L. A systematic primary care office-based smoking cessation program. J Fam Pract 30 (1990) 647-654
93. Kottke T.E., Solberg L.I., Brekke M.L., Conn S.A., Maxwell P., and Brekke M.J. A controlled trial to integrate smoking cessation advice into primary care practice. Doctors Helping Smokers, Round III. J Fam Pract 34 (1992) 701-708
94. McPhee S.J., and Detmer W.M. Office-based interventions to improve delivery of cancer prevention services by primary care physicians. Cancer 72 suppl 3 (1993) 1100-1112
95. Pine D., Sullivan S., Sauser M., and David C. Effects of a systematic approach to tobacco cessation in a community-based practice. Arch Fam Med 6 (1997) 363-367
96. Stone E.G., Morton S.C., Hulscher M.E., et al. Interventions that increase use of adult immunization and cancer screening services. a meta-analysis. Ann Intern Med 136 (2002) 641-651
97. Solberg L.I., Kottke T.E., Conn S.A., Brekke M.L., Calomeni C.A., and Conboy K.S. Delivering clinical preventive services is a systems problem. Ann Behav Med 19 (1997) 271-278
98. Piper M.E., Fiore M.C., Smith S.S., et al. Use of the vital sign stamp as a systematic screening tool to promote smoking cessation. Mayo Clin Proc 78 (2003) 716-722
99. Gordon R.B., Grimshaw J.M., Eccles M., Rowe R.E., and Wyatt J.C. On-screen computer reminders. effects on professional practice and health care outcomes. (Protocol). Cochrane Database Syst Rev 2 (1998) CD001096 DOI: 10.1002/14651858.CD001096.
100. Glasgow R.E., Orleans C.T., and Wagner E.H. Does the chronic care model serve also as a template for improving prevention?. Milbank Q 79 (2001) 579-612 iv-v
101. Boyle R., and Solberg L.I. Is making smoking status a vital sign sufficient to increase cessation support actions in clinical practice?. Ann Fam Med 2 (2004) 22-25
102. McIlvain H.E., Crabtree B.F., Backer E.L., and Turner P.D. Use of office-based smoking cessation activities in family practices. J Fam Pract 49 (2000) 1025-1029
103. Ellerbeck E.F., Ahluwalia J.S., Jolicoeur D.G., Gladden J., and Mosier M.C. Direct observation of smoking cessation activities in primary care practice. J Fam Pract 50 (2001) 688-693
104. Solberg L.I. Incentivising, facilitating, and implementing an office tobacco cessation system. Tob Control 9 suppl 1 (2000) I37-I41
105. Leu R.E., and Schaub T. Does smoking increase medical care expenditure?. Soc Sci Med 17 (1983) 1907-1914
106. Cohen D., and Barton G. The cost to society of smoking cessation. Thorax 53 suppl 2 (1998) S38-S42
107. Max W. The financial impact of smoking on health-related costs. a review of the literature. Am J Health Promot 15 (2001) 321-331
108. Cornuz J., Pinget C., Gilbert A., and Paccaud F. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Clin Pharmacol 59 (2003) 201-206
109. Gold M.R. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York